A second ERAD-associated mechanism regulating lipogenesis involves the E3 ubiquitin ligase HRD1, however the role of HRD1 in NAFLD pathogenesis remains unclear due to conflicting reports (Wei et al., 2018; Li et al., 2021). This evidence concerns the gene SYVN1 and metabolic dysfunction-associated steatotic liver disease.